Back to search

United Kingdom· GB-APID-505511000001102

Dermovate-NN ointment

A medicinal product containing clobetasol + neomycin + nystatin, registered in United Kingdom by Chemidex Pharma Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDermovate-NN ointmentATC—REGISTER NO.GB-APID-5055110000011…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Clobetasol + Neomycin + Nystatin
Manufacturer
Chemidex Pharma Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8b363700-e71c-484f-a2d8-d4f3f2e786a7
GET /v1/drugs/8b363700-e71c-484f-a2d8-d4f3f2e786a7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "505511000001102",
  "desc": "Dermovate-NN ointment (Chemidex Pharma Ltd)",
  "form": "Cutaneous ointment",
  "vpid": "3405411000001104",
  "source": "dmd",
  "vtm_id": "775296009",
  "strength": "500 microgram",
  "substance": "Clobetasol + Neomycin + Nystatin",
  "ingredient": "Clobetasol propionate",
  "supplier_code": "3834801000001102"
}

See everything about clobetasol + neomycin + nystatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.